Haematuria and acute kidney injury in elderly patients admitted to hospital with supratherapeutic warfarin anticoagulation

International Urology and Nephrology

Volumn 45, Issue 2, 2013, Pages 561-570

  Lim, Andy K H ^a,b   Campbell, Donald A ^a,b  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Acute kidney injury; Anticoagulation; Haematuria; Warfarin; Warfarin nephropathy

Indexed keywords

WARFARIN;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE STRUCTURE; FEMALE; FOLLOW UP; HEART FAILURE; HEMATURIA; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; URINALYSIS;

ACUTE KIDNEY INJURY; AGED, 80 AND OVER; ANTICOAGULANTS; FEMALE; HEMATURIA; HOSPITALIZATION; HUMANS; MALE; PROSPECTIVE STUDIES; WARFARIN;

EID: 84880748438     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-012-0364-0     Document Type: Article

References (18)

1. Brodsky SV, Satoskar A, Chen J et al (2009) Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis 54(6):1121-1126
2. Moreno JA, Martin-Cleary C, Gutierrez E et al (2012) AKI associated with macroscopic glomerular hematuria: clinical and pathophysiologic consequences. Clin J Am Soc Nephrol 7(1):175-184
3. Ware K, Brodsky P, Satoskar AA et al (2011) Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation. J Am Soc Nephrol 22(10):1856-1862
4. Ozcan A, Ware K, Calomeni E et al (2012) 5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol 35(4):356-364
5. Brodsky SV, Collins M, Park E et al (2010) Warfarin therapy that results in an international normalization ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease. Nephron Clin Pract 115(2):c142-c146
6. Brodsky SV, Nadasdy T, Rovin BH et al (2011) Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int 80(2):181-189
7. Brodsky SV, Rovin BH, Hebert LA (2012) Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamide. Nephrol Dial Transplant 27(2):475-477
8. Limdi NA, Beasley TM, Baird MF et al (2009) Kidney function influences warfarin responsiveness and hemorrhagic complications. J Am Soc Nephrol 20(4):912-921
9. Kleinow ME, Garwood CL, Clemente JL, Whittaker P (2011) Effect of chronic kidney disease on warfarin management in a pharmacist-managed anticoagulation clinic. J Manag Care Pharm 17(7):523-530
10. Mathew TH, Johnson DW, Jones GR (2007) Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations. Med J Aust 187(8):459-463
11. Ricci Z, Cruz D, Ronco C (2008) The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int 73(5):538-546
12. Baillargeon J, Holmes HM, Lin YL et al (2012) Concurrent use of warfarin and antibiotics and the risk of bleeding in older adults. Am J Med 125(2):183-189
13. Glasheen JJ, Fugit RV, Prochazka AV (2005) The risk of over anticoagulation with antibiotic use in outpatients on stable warfarin regimens. J Gen Intern Med 20(7):653-656
14. Gutierrez E, Gonzalez E, Hernandez E et al (2007) Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy. Clin J Am Soc Nephrol 2(1):51-57
15. Metra M, Nodari S, Parrinello G et al (2008) Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail 10(2):188-195
16. Freda BJ, Slawsky M, Mallidi J, Braden GL (2011) Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics. Am J Kidney Dis 58(6):1005-1017
17. Johnson SG, Rogers K, Delate T, Witt DM (2008) Outcomes associated with combined antiplatelet and anticoagulant therapy. Chest 133(4):948-954
18. Douketis JD (2011) Combination warfarin-ASA therapy: which patients should receive it, which patients should not, and why? Thromb Res 127(6):513-517